Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PCSA Processa Pharmaceuticals, Inc.

盘前交易 05-21 09:13:00 EDT

1.94

-0.02

-1.02%

盘前1.94

+0.000.00%

08:00 EDT

最高2.01	最低1.93	成交量3.04万
今开1.98	昨收1.96	日振幅3.72%
总市值554.06万	流通市值480.06万	总股本285.60万
成交额5.95万	换手率1.23%	流通股本247.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PCSA","market":"US","secType":"STK","nameCN":"Processa Pharmaceuticals, Inc.","latestPrice":1.94,"timestamp":1716235200000,"preClose":1.96,"halted":0,"volume":30413,"hourTrading":{"tag":"盘前","latestPrice":1.94,"preClose":1.94,"latestTime":"08:00 EDT","volume":492,"amount":947.1400488,"timestamp":1716292801026},"delay":0,"floatShares":2474533,"shares":2855981,"eps":-5.987124,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.02,"latestTime":"05-21 09:13:00 EDT","open":1.98,"high":2.005,"low":1.932,"amount":59517.4776337,"amplitude":0.037245,"askPrice":2.98,"askSize":50,"bidPrice":1.04,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-5.987124,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716298200000},"adr":0,"adjPreClose":1.94,"preHourTrading":{"tag":"盘前","latestPrice":1.94,"preClose":1.94,"latestTime":"08:00 EDT","volume":492,"amount":947.1400488,"timestamp":1716292801026},"postHourTrading":{"tag":"盘后","latestPrice":1.92,"preClose":1.94,"latestTime":"16:48 EDT","volume":1132,"amount":2173.44,"timestamp":1716238136458},"volumeRatio":0.5214312661812207},"requestUrl":"/m/hq/s/PCSA/","defaultTab":"news","newsList":[{"id":"2435322888","title":"Processa 制药公司公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435322888","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2435322888?lang=zh_cn&edition=full","pubTime":"2024-05-13 20:21","pubTimestamp":1715602871,"startTime":"0","endTime":"0","summary":"   * Processa Pharmaceuticals Inc    公布了截至 3 月份的季度调整后每股亏损 1.11 美元，高于去年同期的每股收益 3.60 美元。分析师对该季度的唯一预测是每股亏损 1.18 美元。* Processa Pharmaceuticals Inc 报告的本季度每股收益为亏损 1.11 美元。* 该公司的季度亏损额为 273 万美元。* 本季度，Processa Pharmaceuticals Inc 的股价下跌了 11.6%，今年迄今为止下跌了 68.8%。* 医药同行的平均一致建议也是 \"买入\"。华尔街对 Processa Pharmaceuticals Inc 的 12 个月目标价中位数为 44.00 美元。本摘要由 LSEG 于世界协调时 5 月 13 日中午 12:20 的调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2434326448","title":"Processa Pharmaceuticals Inc    预计每股亏损 1.18 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434326448","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434326448?lang=zh_cn&edition=full","pubTime":"2024-05-10 19:13","pubTimestamp":1715339623,"startTime":"0","endTime":"0","summary":"   * Processa Pharmaceuticals Inc    预计将于5月13日公布截至2024年3月31日的财报(预计)    *    * LSEG分析师对Processa Pharmaceuticals Inc的平均预期是每股亏损1.18美元。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 2 个 \"强烈买入 \"或 \"买入\"，1 个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Processa Pharmaceuticals Inc 的 12 个月目标价中位数为 44.00 美元，高于上一次收盘价 2.13 美元。5月10日 - 本摘要于北京时间 5 月 10 日 11:13 机器生成。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2434363014","title":"Processa Pharmaceuticals, Inc.盘中异动 急速下挫6.45%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434363014","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434363014?lang=zh_cn&edition=full","pubTime":"2024-05-09 23:14","pubTimestamp":1715267662,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日23时14分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速下挫6.45%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。其相关个股中，Seres Therapeutics, Inc.、G1 Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Notable Labs, Ltd.、Allarity Therapeutics, Inc.、G1 Therapeutics, Inc.较为活跃，换手率分别为146.96%、114.96%、32.14%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Notable Labs, Ltd.、G1 Therapeutics, Inc.，振幅分别为58.46%、57.24%、40.79%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092314227a5904a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092314227a5904a4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433043824","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433043824","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433043824?lang=zh_cn&edition=full","pubTime":"2024-05-07 00:14","pubTimestamp":1715012071,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日00时14分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.04%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nrx Pharmaceuticals, Inc.、Tc Biopharm  Plc涨幅较大，Tc Biopharm  Plc、Allarity Therapeutics, Inc.、Lyra Therapeutics, Inc.较为活跃，换手率分别为1167.58%、763.39%、98.91%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.，振幅分别为95.51%、84.25%、68.10%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405070014317a584b87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405070014317a584b87&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431869801","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅跳水5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431869801","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431869801?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:31","pubTimestamp":1714397466,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时31分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.58%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Soleno Therapeutics, Inc.、Zyversa Therapeutics, Inc.、Immunitybio, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为390.93%、22.51%、9.65%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Calcimedica, Inc.，振幅分别为19.05%、13.83%、10.09%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429213106861ea152&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429213106861ea152&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430286519","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘大幅上涨49.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430286519","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430286519?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:31","pubTimestamp":1714051865,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时31分，Processa Pharmaceuticals, Inc.股票出现波动，股价急速拉升49.01%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。消息层面，截至21时31分，《Processa Pharma获HC Wainwright & Co.首次覆盖，给予买入评级, 目标价8.00美元。》资讯为影响Processa Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521310687af6721&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521310687af6721&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430405568","title":"Processa Pharma(PCSA.US)获HC Wainwright & Co.首次覆盖，给予买入评级, 目标价8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2430405568","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430405568?lang=zh_cn&edition=full","pubTime":"2024-04-25 18:46","pubTimestamp":1714041988,"startTime":"0","endTime":"0","summary":"Processa Pharma(PCSA.US)获HC Wainwright & Co.首次覆盖，给予买入评级, 目标价8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251846348b52b68b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251846348b52b68b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429141231","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大涨5.56%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429141231","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429141231?lang=zh_cn&edition=full","pubTime":"2024-04-23 23:32","pubTimestamp":1713886337,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日23时32分，Processa Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.56%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Nkgen Biotech, Inc.较为活跃，换手率分别为2484.67%、177.51%、37.41%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Palisade Bio, Inc.、Moolec Science Sa C/Wts ，振幅分别为80.08%、45.43%、38.82%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232332177922b54a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232332177922b54a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429920833","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.06%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429920833","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429920833?lang=zh_cn&edition=full","pubTime":"2024-04-22 22:41","pubTimestamp":1713796862,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日22时41分，Processa Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.06%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.05%。其相关个股中，Moolec Science Sa C/Wts 、Moolec Science Sa、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Moolec Science Sa、Adial Pharmaceuticals, Inc、Nkgen Biotech, Inc.较为活跃，换手率分别为166.61%、56.94%、47.55%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、亚狮康药业，振幅分别为198.51%、68.57%、31.66%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042222410287e82870&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042222410287e82870&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428459731","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅跳水5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428459731","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428459731?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:59","pubTimestamp":1713448740,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时59分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.30%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Bio-Path Holdings, Inc.、Aileron Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Bio-Path Holdings, Inc.、Benitec Biopharma Inc.、Soligenix, Inc.较为活跃，换手率分别为4356.32%、79.14%、28.15%，振幅较大的相关个股有Bio-Path Holdings, Inc.、Aileron Therapeutics, Inc.、Prokidney Corp.，振幅分别为86.72%、34.82%、29.11%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418215901861e7152&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418215901861e7152&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427021920","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅下跌7.19%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427021920","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427021920?lang=zh_cn&edition=full","pubTime":"2024-04-15 22:23","pubTimestamp":1713190999,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日22时23分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速跳水7.19%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，安皮奥制药、Ocean Biomedical Inc C/Wts 14/02/2028 、Soligenix, Inc.涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1166.07%、964.14%、732.65%，振幅较大的相关个股有安皮奥制药、Cassava Sciences Inc C/Wts 15/11/2024、Soligenix, Inc.，振幅分别为273.33%、80.04%、79.05%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152223197a52dd05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152223197a52dd05&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426787936","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.11%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426787936","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426787936?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:30","pubTimestamp":1712928604,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日21时30分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.11%。截至发稿，该股报1.67美元/股，成交量3996股，换手率0.14%，振幅0.00%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Renovaro Inc.、Vaxxinity, Inc.、Windtree Therapeutics, Inc.涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为816.97%、416.45%、23.10%，振幅较大的相关个股有Zymeworks Inc.、Zyversa Therapeutics, Inc.、Zevra Therapeutics, Inc.，振幅分别为0.00%、0.00%、0.00%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041221300587e7ff03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041221300587e7ff03&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426263857","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘急速跳水5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426263857","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426263857?lang=zh_cn&edition=full","pubTime":"2024-04-11 22:01","pubTimestamp":1712844108,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日22时01分，Processa Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.83%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，Eliem Therapeutics, Inc、Rallybio Corporation、Alpine Immune Sciences, Inc.涨幅较大，Scisparc Ltd.、Aptevo Therapeutics Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为403.44%、364.20%、249.18%，振幅较大的相关个股有Rallybio Corporation、Tc Biopharm  Plc C/Wts 10/02/2028 、Adial Pharmaceuticals, Inc，振幅分别为50.92%、46.31%、25.32%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112201487a522d6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112201487a522d6d&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.processapharmaceuticals.com","stockEarnings":[{"period":"1week","weight":-0.1261},{"period":"1month","weight":0.2278},{"period":"3month","weight":-0.2177},{"period":"6month","weight":-0.7771},{"period":"1year","weight":-0.853},{"period":"ytd","weight":-0.7101}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0705},{"period":"3month","weight":0.067},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.1152}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Processa Pharmaceuticals, Inc.成立于2011年3月29日。该公司是一家临床阶段的生物制药公司，致力于药物产品的开发，该产品旨在为高度未满足的患者提供治疗方法并改善其生存率和生活质量。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.245296},{"month":2,"riseRate":0.666667,"avgChangeRate":0.111339},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.094091},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.072959},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.065592},{"month":6,"riseRate":0.666667,"avgChangeRate":0.113324},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.116934},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.064365},{"month":9,"riseRate":0.666667,"avgChangeRate":0.119026},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.111719},{"month":11,"riseRate":0.333333,"avgChangeRate":0.108897},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.158361}],"exchange":"NASDAQ","name":"Processa Pharmaceuticals, Inc.","nameEN":"Processa Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Processa Pharmaceuticals, Inc.,PCSA,Processa Pharmaceuticals, Inc.股票,Processa Pharmaceuticals, Inc.股票老虎,Processa Pharmaceuticals, Inc.股票老虎国际,Processa Pharmaceuticals, Inc.行情,Processa Pharmaceuticals, Inc.股票行情,Processa Pharmaceuticals, Inc.股价,Processa Pharmaceuticals, Inc.股市,Processa Pharmaceuticals, Inc.股票价格,Processa Pharmaceuticals, Inc.股票交易,Processa Pharmaceuticals, Inc.股票购买,Processa Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况